Learn how to read the data. There is nothing to learn here other than how the CEO's of these OTC's manipulate shareholders. When only a hand full of CEO's in a sea of over 10,000 OTC companies has good intentions, then there's something blatantly wrong with the system. It affects only small retail, so FINRA/SEC could care less, and the rules don't change.